medicaid approved glp 1 weight loss Did we prescribe a GLP-1 medication for you last year? States Are Walking Back Medicaid

10.1146/annurev-biophys-111622-091155 252 HemmingsH

Semaglutide and tirzepatide have transformed weight loss treatment, with clinical trials showing patients lose 15-22% of body weight

In the current study, the researchers demonstrated that semaglutide reduced binge-like alcohol drinking in both male and female mice, and that the effect was dose-dependent (i.e., greater amounts of semaglutide led to greater reductions in binge alcohol intake)

The most common adverse reactions included diarrhea, vomiting, elevated blood urea nitrogen, polydipsia, and hypersalivation

Biomarkers 2009

Ingredients like zinc, vitamin D, D-aspartic acid, and fenugreek are commonly found in these products